Compile Data Set for Download or QSAR
Report error Found 140 Enz. Inhib. hit(s) with all data for entry = 10224
TargetVasopressin V1a receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandChemical structure of BindingDB Monomer ID 521144BDBM521144(US11149023, Example 39)
Affinity DataIC50: 0.480nMAssay Description:The identification of agonists and antagonists of the V1a and V2 vasopressin receptors from humans, rats and dogs as well as the quantification of th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
US Patent

TargetVasopressin V1a receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandChemical structure of BindingDB Monomer ID 521168BDBM521168(N-{3-[3-(4-Chlorophenyl)-5-oxo-1-({1-[3-(trifluoro...)
Affinity DataIC50: 0.720nMAssay Description:The identification of agonists and antagonists of the V1a and V2 vasopressin receptors from humans, rats and dogs as well as the quantification of th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
US Patent

TargetVasopressin V1a receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandChemical structure of BindingDB Monomer ID 521140BDBM521140(US11149023, Example 34)
Affinity DataIC50: 0.820nMAssay Description:The identification of agonists and antagonists of the V1a and V2 vasopressin receptors from humans, rats and dogs as well as the quantification of th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
US Patent

TargetVasopressin V1a receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandChemical structure of BindingDB Monomer ID 521129BDBM521129(tert-Butyl 3-({3-[3-(4-chlorophenyl)-1-{[1-(3-chlo...)
Affinity DataIC50: 1.01nMAssay Description:The identification of agonists and antagonists of the V1a and V2 vasopressin receptors from humans, rats and dogs as well as the quantification of th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
US Patent

TargetVasopressin V1a receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandChemical structure of BindingDB Monomer ID 521172BDBM521172(N-{3-[3-(4-Chlorophenyl)-5-oxo-1-({1-[3-(trifluoro...)
Affinity DataIC50: 1.15nMAssay Description:The identification of agonists and antagonists of the V1a and V2 vasopressin receptors from humans, rats and dogs as well as the quantification of th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
US Patent

TargetVasopressin V1a receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandChemical structure of BindingDB Monomer ID 521138BDBM521138(N-{3-[3-(4-Chlorophenyl)-1-{[1-(3-chloropyridin-2-...)
Affinity DataIC50: 1.17nMAssay Description:The identification of agonists and antagonists of the V1a and V2 vasopressin receptors from humans, rats and dogs as well as the quantification of th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
US Patent

TargetVasopressin V1a receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandChemical structure of BindingDB Monomer ID 521169BDBM521169(N-{3-[3-(4-Chlorophenyl)-5-oxo-1-({1-[3-(trifluoro...)
Affinity DataIC50: 1.20nMAssay Description:The identification of agonists and antagonists of the V1a and V2 vasopressin receptors from humans, rats and dogs as well as the quantification of th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
US Patent

TargetVasopressin V1a receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandChemical structure of BindingDB Monomer ID 521117BDBM521117(N-{3-[3-(4-Chlorophenyl)-1-{[1-(3-chloropyridin-2-...)
Affinity DataIC50: 1.20nMAssay Description:The identification of agonists and antagonists of the V1a and V2 vasopressin receptors from humans, rats and dogs as well as the quantification of th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
US Patent

TargetVasopressin V1a receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandChemical structure of BindingDB Monomer ID 521151BDBM521151(US11149023, Example 46)
Affinity DataIC50: 1.35nMAssay Description:The identification of agonists and antagonists of the V1a and V2 vasopressin receptors from humans, rats and dogs as well as the quantification of th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
US Patent

TargetVasopressin V1a receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandChemical structure of BindingDB Monomer ID 521148BDBM521148(US11149023, Example 43)
Affinity DataIC50: 1.40nMAssay Description:The identification of agonists and antagonists of the V1a and V2 vasopressin receptors from humans, rats and dogs as well as the quantification of th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
US Patent

TargetVasopressin V1a receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandChemical structure of BindingDB Monomer ID 521146BDBM521146(N-{3-[3-(4-Chlorophenyl)-1-{[1-(3-chloropyridin-2-...)
Affinity DataIC50: 1.5nMAssay Description:The identification of agonists and antagonists of the V1a and V2 vasopressin receptors from humans, rats and dogs as well as the quantification of th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
US Patent

TargetVasopressin V1a receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandChemical structure of BindingDB Monomer ID 521167BDBM521167(N-{3-[3-(4-Chlorophenyl)-5-oxo-1-({1-[3-(trifluoro...)
Affinity DataIC50: 1.60nMAssay Description:The identification of agonists and antagonists of the V1a and V2 vasopressin receptors from humans, rats and dogs as well as the quantification of th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
US Patent

TargetVasopressin V1a receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandChemical structure of BindingDB Monomer ID 521158BDBM521158(N-{3-[3-(4-Chlorophenyl)-1-{[1-(3-chloropyridin-2-...)
Affinity DataIC50: 1.60nMAssay Description:The identification of agonists and antagonists of the V1a and V2 vasopressin receptors from humans, rats and dogs as well as the quantification of th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
US Patent

TargetVasopressin V1a receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandChemical structure of BindingDB Monomer ID 521113BDBM521113(N-{3-[3-(4-Chlorophenyl)-1-{[1-(3-chloropyridin-2-...)
Affinity DataIC50: 1.65nMAssay Description:The identification of agonists and antagonists of the V1a and V2 vasopressin receptors from humans, rats and dogs as well as the quantification of th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
US Patent

TargetVasopressin V1a receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandChemical structure of BindingDB Monomer ID 521143BDBM521143(N-{3-[3-(4-Chlorophenyl)-1-{[1-(3-chloropyridin-2-...)
Affinity DataIC50: 1.70nMAssay Description:The identification of agonists and antagonists of the V1a and V2 vasopressin receptors from humans, rats and dogs as well as the quantification of th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
US Patent

TargetVasopressin V1a receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandChemical structure of BindingDB Monomer ID 521131BDBM521131((2E)-N-{3-[3-(4-Chlorophenyl)-1-{[1-(3-chloropyrid...)
Affinity DataIC50: 1.75nMAssay Description:The identification of agonists and antagonists of the V1a and V2 vasopressin receptors from humans, rats and dogs as well as the quantification of th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
US Patent

TargetVasopressin V1a receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandChemical structure of BindingDB Monomer ID 521149BDBM521149(N-{3-[3-(4-Chlorophenyl)-1-{[1-(3-chloropyridin-2-...)
Affinity DataIC50: 1.75nMAssay Description:The identification of agonists and antagonists of the V1a and V2 vasopressin receptors from humans, rats and dogs as well as the quantification of th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
US Patent

TargetVasopressin V1a receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandChemical structure of BindingDB Monomer ID 521152BDBM521152(N-{3-[3-(4-Chlorophenyl)-1-{[1-(3-chloropyridin-2-...)
Affinity DataIC50: 1.85nMAssay Description:The identification of agonists and antagonists of the V1a and V2 vasopressin receptors from humans, rats and dogs as well as the quantification of th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
US Patent

TargetVasopressin V1a receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandChemical structure of BindingDB Monomer ID 521134BDBM521134(tert-Butyl [1-({3-[3-(4-chlorophenyl)-1-{[1-(3-chl...)
Affinity DataIC50: 1.85nMAssay Description:The identification of agonists and antagonists of the V1a and V2 vasopressin receptors from humans, rats and dogs as well as the quantification of th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
US Patent

TargetVasopressin V1a receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandChemical structure of BindingDB Monomer ID 521164BDBM521164(N-{3-[3-(4-Chlorophenyl)-5-oxo-1-({1-[3-(trifluoro...)
Affinity DataIC50: 1.90nMAssay Description:The identification of agonists and antagonists of the V1a and V2 vasopressin receptors from humans, rats and dogs as well as the quantification of th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
US Patent

TargetVasopressin V1a receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandChemical structure of BindingDB Monomer ID 521160BDBM521160(N-{3-[3-(4-Chlorophenyl)-1-{[1-(3-chloropyridin-2-...)
Affinity DataIC50: 1.95nMAssay Description:The identification of agonists and antagonists of the V1a and V2 vasopressin receptors from humans, rats and dogs as well as the quantification of th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
US Patent

TargetVasopressin V1a receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandChemical structure of BindingDB Monomer ID 521174BDBM521174(N-{3-[3-(4-Chlorophenyl)-5-oxo-1-({1-[3-(trifluoro...)
Affinity DataIC50: 1.95nMAssay Description:The identification of agonists and antagonists of the V1a and V2 vasopressin receptors from humans, rats and dogs as well as the quantification of th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
US Patent

TargetVasopressin V1a receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandChemical structure of BindingDB Monomer ID 521121BDBM521121(N-{3-[3-(4-Chlorophenyl)-1-{[1-(3-chloropyridin-2-...)
Affinity DataIC50: 2.05nMAssay Description:The identification of agonists and antagonists of the V1a and V2 vasopressin receptors from humans, rats and dogs as well as the quantification of th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
US Patent

TargetVasopressin V1a receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandChemical structure of BindingDB Monomer ID 521125BDBM521125(N-{3-[3-(4-Chlorophenyl)-1-{[1-(3-chloropyridin-2-...)
Affinity DataIC50: 2.20nMAssay Description:The identification of agonists and antagonists of the V1a and V2 vasopressin receptors from humans, rats and dogs as well as the quantification of th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
US Patent

TargetVasopressin V1a receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandChemical structure of BindingDB Monomer ID 521124BDBM521124(N-{3-[3-(4-Chlorophenyl)-1-{[1-(3-chloropyridin-2-...)
Affinity DataIC50: 2.5nMAssay Description:The identification of agonists and antagonists of the V1a and V2 vasopressin receptors from humans, rats and dogs as well as the quantification of th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
US Patent

TargetVasopressin V1a receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandChemical structure of BindingDB Monomer ID 521157BDBM521157(5-Chloro-N-{3-[3-(4-chlorophenyl)-1-{[1-(3-chlorop...)
Affinity DataIC50: 2.80nMAssay Description:The identification of agonists and antagonists of the V1a and V2 vasopressin receptors from humans, rats and dogs as well as the quantification of th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
US Patent

TargetVasopressin V1a receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandChemical structure of BindingDB Monomer ID 521156BDBM521156(N-{3-[3-(4-Chlorophenyl)-1-{[1-(3-chloropyridin-2-...)
Affinity DataIC50: 2.90nMAssay Description:The identification of agonists and antagonists of the V1a and V2 vasopressin receptors from humans, rats and dogs as well as the quantification of th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
US Patent

TargetVasopressin V1a receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandChemical structure of BindingDB Monomer ID 521163BDBM521163(N-{3-[3-(4-Chlorophenyl)-5-oxo-1-({1-[3-(trifluoro...)
Affinity DataIC50: 3nMAssay Description:The identification of agonists and antagonists of the V1a and V2 vasopressin receptors from humans, rats and dogs as well as the quantification of th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
US Patent

TargetVasopressin V1a receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandChemical structure of BindingDB Monomer ID 521155BDBM521155(N-{3-[3-(4-Chlorophenyl)-1-{[1-(3-chloropyridin-2-...)
Affinity DataIC50: 3.20nMAssay Description:The identification of agonists and antagonists of the V1a and V2 vasopressin receptors from humans, rats and dogs as well as the quantification of th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
US Patent

TargetVasopressin V1a receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandChemical structure of BindingDB Monomer ID 521154BDBM521154(N-{3-[3-(4-Chlorophenyl)-1-{[1-(3-chloropyridin-2-...)
Affinity DataIC50: 3.35nMAssay Description:The identification of agonists and antagonists of the V1a and V2 vasopressin receptors from humans, rats and dogs as well as the quantification of th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
US Patent

TargetVasopressin V1a receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandChemical structure of BindingDB Monomer ID 521137BDBM521137(N-{3-[3-(4-Chlorophenyl)-1-{[1-(3-chloropyridin-2-...)
Affinity DataIC50: 3.40nMAssay Description:The identification of agonists and antagonists of the V1a and V2 vasopressin receptors from humans, rats and dogs as well as the quantification of th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
US Patent

TargetVasopressin V1a receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandChemical structure of BindingDB Monomer ID 521141BDBM521141(US11149023, Example 36)
Affinity DataIC50: 3.5nMAssay Description:The identification of agonists and antagonists of the V1a and V2 vasopressin receptors from humans, rats and dogs as well as the quantification of th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
US Patent

TargetVasopressin V1a receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandChemical structure of BindingDB Monomer ID 521159BDBM521159(tert-Butyl 2-({3-[3-(4-chlorophenyl)-1-{[1-(3-chlo...)
Affinity DataIC50: 3.90nMAssay Description:The identification of agonists and antagonists of the V1a and V2 vasopressin receptors from humans, rats and dogs as well as the quantification of th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
US Patent

TargetVasopressin V1a receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandChemical structure of BindingDB Monomer ID 521128BDBM521128(N-{3-[3-(4-Chlorophenyl)-1-{[1-(3-chloropyridin-2-...)
Affinity DataIC50: 4.05nMAssay Description:The identification of agonists and antagonists of the V1a and V2 vasopressin receptors from humans, rats and dogs as well as the quantification of th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
US Patent

TargetVasopressin V1a receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandChemical structure of BindingDB Monomer ID 521109BDBM521109(N-{3-[3-(4-Chlorophenyl)-1-{[1-(3-chloropyridin-2-...)
Affinity DataIC50: 4.10nMAssay Description:The identification of agonists and antagonists of the V1a and V2 vasopressin receptors from humans, rats and dogs as well as the quantification of th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
US Patent

TargetVasopressin V1a receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandChemical structure of BindingDB Monomer ID 521130BDBM521130(N-{3-[3-(4-Chlorophenyl)-1-{[1-(3-chloropyridin-2-...)
Affinity DataIC50: 4.40nMAssay Description:The identification of agonists and antagonists of the V1a and V2 vasopressin receptors from humans, rats and dogs as well as the quantification of th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
US Patent

TargetVasopressin V1a receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandChemical structure of BindingDB Monomer ID 521176BDBM521176(N-{3-[3-(4-Chlorophenyl)-5-oxo-1-({1-[3-(trifluoro...)
Affinity DataIC50: 4.90nMAssay Description:The identification of agonists and antagonists of the V1a and V2 vasopressin receptors from humans, rats and dogs as well as the quantification of th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
US Patent

TargetVasopressin V1a receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandChemical structure of BindingDB Monomer ID 521107BDBM521107(N-{3-[3-(4-Chlorophenyl)-1-{[1-(3-chloropyridin-2-...)
Affinity DataIC50: 4.90nMAssay Description:The identification of agonists and antagonists of the V1a and V2 vasopressin receptors from humans, rats and dogs as well as the quantification of th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
US Patent

TargetVasopressin V1a receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandChemical structure of BindingDB Monomer ID 521122BDBM521122(1-({3-[3-(4-Chlorophenyl)-1-{[1-(3-chloropyridin-2...)
Affinity DataIC50: 5.05nMAssay Description:The identification of agonists and antagonists of the V1a and V2 vasopressin receptors from humans, rats and dogs as well as the quantification of th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
US Patent

TargetVasopressin V1a receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandChemical structure of BindingDB Monomer ID 521153BDBM521153(N-{3-[3-(4-Chlorophenyl)-1-{[1-(3-chloropyridin-2-...)
Affinity DataIC50: 5.40nMAssay Description:The identification of agonists and antagonists of the V1a and V2 vasopressin receptors from humans, rats and dogs as well as the quantification of th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
US Patent

TargetVasopressin V1a receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandChemical structure of BindingDB Monomer ID 521171BDBM521171(N-{3-[3-(4-Chlorophenyl)-5-oxo-1-({1-[3-(trifluoro...)
Affinity DataIC50: 5.40nMAssay Description:The identification of agonists and antagonists of the V1a and V2 vasopressin receptors from humans, rats and dogs as well as the quantification of th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
US Patent

TargetVasopressin V1a receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandChemical structure of BindingDB Monomer ID 521135BDBM521135(1-Amino-N-{3-[3-(4-chlorophenyl)-1-{[1-(3-chloropy...)
Affinity DataIC50: 5.65nMAssay Description:The identification of agonists and antagonists of the V1a and V2 vasopressin receptors from humans, rats and dogs as well as the quantification of th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
US Patent

TargetVasopressin V1a receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandChemical structure of BindingDB Monomer ID 521112BDBM521112(N-{3-[3-(4-Chlorophenyl)-1-{[1-(3-chloropyridin-2-...)
Affinity DataIC50: 5.65nMAssay Description:The identification of agonists and antagonists of the V1a and V2 vasopressin receptors from humans, rats and dogs as well as the quantification of th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
US Patent

TargetVasopressin V1a receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandChemical structure of BindingDB Monomer ID 521127BDBM521127(N-{(3-[3-(4-Chlorophenyl)-1-{[1-(3-chloropyridin-2...)
Affinity DataIC50: 5.95nMAssay Description:The identification of agonists and antagonists of the V1a and V2 vasopressin receptors from humans, rats and dogs as well as the quantification of th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
US Patent

TargetVasopressin V1a receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandChemical structure of BindingDB Monomer ID 521116BDBM521116(N-{(3-[3-(4-Chlorophenyl)-1-{[1-(3-chloropyridin-2...)
Affinity DataIC50: 6.10nMAssay Description:The identification of agonists and antagonists of the V1a and V2 vasopressin receptors from humans, rats and dogs as well as the quantification of th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
US Patent

TargetVasopressin V1a receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandChemical structure of BindingDB Monomer ID 521173BDBM521173(N-{3-[3-(4-Chlorophenyl)-5-oxo-1-({1-[3-(trifluoro...)
Affinity DataIC50: 6.15nMAssay Description:The identification of agonists and antagonists of the V1a and V2 vasopressin receptors from humans, rats and dogs as well as the quantification of th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
US Patent

TargetVasopressin V1a receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandChemical structure of BindingDB Monomer ID 521136BDBM521136(N-{3-[3-(4-Chlorophenyl)-1-{[1-(3-chloropyridin-2-...)
Affinity DataIC50: 6.30nMAssay Description:The identification of agonists and antagonists of the V1a and V2 vasopressin receptors from humans, rats and dogs as well as the quantification of th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
US Patent

TargetVasopressin V1a receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandChemical structure of BindingDB Monomer ID 521175BDBM521175(N-{3-[3-(4-Chlorophenyl)-5-oxo-1-({1-[3-(trifluoro...)
Affinity DataIC50: 6.35nMAssay Description:The identification of agonists and antagonists of the V1a and V2 vasopressin receptors from humans, rats and dogs as well as the quantification of th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
US Patent

TargetVasopressin V1a receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandChemical structure of BindingDB Monomer ID 521119BDBM521119(N-{3-[3-(4-Chlorophenyl)-1-{[1-(3-chloropyridin-2-...)
Affinity DataIC50: 6.95nMAssay Description:The identification of agonists and antagonists of the V1a and V2 vasopressin receptors from humans, rats and dogs as well as the quantification of th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
US Patent

TargetVasopressin V1a receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandChemical structure of BindingDB Monomer ID 521161BDBM521161(tert-Butyl 2-({3-[3-(4-chlorophenyl)-1-{[1-(3-chlo...)
Affinity DataIC50: 8.10nMAssay Description:The identification of agonists and antagonists of the V1a and V2 vasopressin receptors from humans, rats and dogs as well as the quantification of th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2022
Entry Details
US Patent

Displayed 1 to 50 (of 140 total ) | Next | Last >>
Jump to: